Mechanisms underlying HIV-1 Vpu-mediated viral egress

Frontiers in Microbiology

Volumn 5, Issue MAY, 2014, Pages

  Roy, Nicolas ^a,b   Pacini, Grégory ^a,b   Berlioz Torrent, Clarisse ^a,b   Janvier, Katy ^a,b  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

BST2 Tetherin; CD4; Cell surface down regulation; Degradation; ESCRT; HIV 1; NF B; Vpu

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; ESCRT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; NTB A PROTEIN; PROTEIN; TETHERIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VPU PROTEIN;

ANTIBIOSIS; ANTIVIRAL ACTIVITY; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL SURFACE; DOWN REGULATION; ESCAPE BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE EVASION; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; VIRUS PATHOGENESIS; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 84904860025     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00177     Document Type: Short Survey

References (81)

1. Agromayor, M., Soler, N., Caballe, A., Kueck, T., Freund, S. M., Allen, M. D., et al. (2012). The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain. Structure 20, 414-428. doi: 10.1016/j.str.2011.12.013
2. Bailes, E., Gao, F., Bibollet-Ruche, F., Courgnaud, V., Peeters, M., Marx, P. A., et al. (2003). Hybrid origin of SIV in chimpanzees. Science 300, 1713. doi: 10.1126/science.1080657
3. Besnard-Guerin, C., Belaidouni, N., Lassot, I., Segeral, E., Jobart, A., Marchal, C., et al. (2004). HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates. J. Biol. Chem. 279, 788-795. doi: 10.1074/jbc.M308068200
4. Billcliff, P. G., Rollason, R., Prior, I., Owen, D. M., Gaus, K., and Banting, G. (2013). CD317/tetherin is an organiser of membrane microdomains. J. Cell Sci. 126, 1553-1564. doi: 10.1242/jcs.112953
5. Bour, S., Perrin, C., Akari, H., and Strebel, K. (2001). The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J. Biol. Chem. 276, 15920-15928. doi: 10.1074/jbc.M010533200
6. Caillet, M., Janvier, K., Pelchen-Matthews, A., Delcroix-Genete, D., Camus, G., Marsh, M., et al. (2011). Rab7A is required for efficient production of infectious HIV-1. PLoS Pathog. 7:e1002347. doi: 10.1371/journal.ppat.1002347
7. Casartelli, N., Sourisseau, M., Feldmann, J., Guivel-Benhassine, F., Mallet, A., Marcelin, A. G., et al. (2010). Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog. 6:e1000955. doi: 10.1371/journal.ppat.1000955
8. Chaudhuri, R., Lindwasser, O. W., Smith, W. J., Hurley, J. H., and Bonifacino, J. S. (2007). Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor. J. Virol. 81, 3877-3890. doi: 10.1128/JVI.02725-06
9. Chu, H., Wang, J. J., Qi, M., Yoon, J. J., Chen, X., Wen, X., et al. (2012). Tetherin/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages. Cell Host Microbe 12, 360-372. doi: 10.1016/j.chom.2012.07.011
10. Cocka, L. J., and Bates, P. (2012). Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities. PLoS Pathog. 8:e1002931. doi: 10.1371/journal.ppat.1002931
11. Courgnaud, V., Formenty, P., Akoua-Koffi, C., Noe, R., Boesch, C., Delaporte, E., et al. (2003). Partial molecular characterization of two simian immunodeficiency viruses (SIV) from African colobids: SIVwrc from Western red colobus (Piliocolobus badius) and SIVolc from olive colobus (Procolobus verus). J. Virol. 77, 744-748. doi: 10.1128/JVI.77.1.744-748.2003
12. Courgnaud, V., Salemi, M., Pourrut, X., Mpoudi-Ngole, E., Abela, B., Auzel, P., et al. (2002). Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. J. Virol. 76, 8298-8309. doi: 10.1128/JVI.76.16.8298-8309.2002
13. Crise, B., Buonocore, L., and Rose, J. K. (1990). CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J. Virol. 64, 5585-5593.
14. Douglas, J. L., Viswanathan, K., McCarroll, M. N., Gustin, J. K., Fruh, K., and Moses, A. V. (2009). Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J. Virol. 83, 7931-7947. doi: 10.1128/JVI.00242-09
15. Dube, M., Paquay, C., Roy, B. B., Bego, M. G., Mercier, J., and Cohen, E. A. (2011). HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface. Traffic 12, 1714-1729. doi: 10.1111/j.1600-0854.2011.01277.x
16. Galao, R. P., Le Tortorec, A., Pickering, S., Kueck, T., and Neil, S. J. (2012). Innate sensing of HIV-1 assembly by Tetherin induces NFkappaB-dependent proinflammatory responses. Cell Host Microbe 12, 633-644. doi: 10.1016/j.chom.2012.10.007
17. Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., et al. (1999). Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397, 436-441. doi: 10.1038/17130
18. Goffinet, C., Allespach, I., Homann, S., Tervo, H. M., Habermann, A., Rupp, D., et al. (2009). HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 5, 285-297. doi: 10.1016/j.chom.2009.01.009
19. Goffinet, C., Homann, S., Ambiel, I., Tibroni, N., Rupp, D., Keppler, O. T., et al. (2010). Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu. J. Virol. 84, 4089-4094. doi: 10.1128/JVI.01549-09
20. Gummuluru, S., Kinsey, C. M., and Emerman, M. (2000). An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus. J. Virol. 74, 10882-10891. doi: 10.1128/JVI.74.23.10882-10891.2000
21. Gupta, R. K., Hue, S., Schaller, T., Verschoor, E., Pillay, D., and Towers, G. J. (2009a). Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 5:e1000443. doi: 10.1371/journal.ppat.1000443
22. Gupta, R. K., Mlcochova, P., Pelchen-Matthews, A., Petit, S. J., Mattiuzzo, G., Pillay, D., et al. (2009b). Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc. Natl. Acad. Sci. U.S.A. 106, 20889-20894. doi: 10.1073/pnas.0907075106
23. Gustin, J. K., Douglas, J. L., Bai, Y., and Moses, A. V. (2012). Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain. J. Biol. Chem. 287, 14837-14850. doi: 10.1074/jbc.M112.349928
24. Habermann, A., Krijnse-Locker, J., Oberwinkler, H., Eckhardt, M., Homann, S., Andrew, A., et al. (2010). CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J. Virol. 84, 4646-4658. doi: 10.1128/JVI.02421-09
25. Hammonds, J., Wang, J. J., Yi, H., and Spearman, P. (2010). Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog. 6:e1000749. doi: 10.1371/journal.ppat.1000749
26. Hauser, H., Lopez, L. A., Yang, S. J., Oldenburg, J. E., Exline, C. M., Guatelli, J. C., et al. (2010). HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 7, 51. doi: 10.1186/1742-4690-7-51
27. Hill, M. S., Ruiz, A., Schmitt, K., and Stephens, E. B. (2010). Identification of amino acids within the second alpha helical domain of the human immunodeficiency virus type 1 Vpu that are critical for preventing CD4 cell surface expression. Virology 397, 104-112. doi: 10.1016/j.virol.2009.10.048
28. Iwabu, Y., Fujita, H., Kinomoto, M., Kaneko, K., Ishizaka, Y., Tanaka, Y., et al. (2009). HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 284, 35060-35072. doi: 10.1074/jbc.M109.058305
29. Jabbar, M. A., and Nayak, D. P. (1990). Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane. J. Virol. 64, 6297-6304.
30. Janvier, K., Pelchen-Matthews, A., Renaud, J. B., Caillet, M., Marsh, M., and Berlioz-Torrent, C. (2011). The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation. PLoS Pathog. 7:e1001265. doi: 10.1371/journal.ppat.1001265
31. Janvier, K., Roy, N., and Berlioz-Torrent, C. (2012). Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin. Curr. HIV Res. 10, 315-320. doi: 10.2174/157016212800792414
32. Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., et al. (2009). Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 5:e1000429. doi: 10.1371/journal.ppat.1000429
33. Jolly, C., Booth, N. J., and Neil, S. J. (2010). Cell-cell spread of human immunodeficiency virus type-1 overcomes tetherin/BST-2 mediated restriction in T cells. J. Virol. 84, 12185-12199. doi: 10.1128/JVI.01447-10
34. Kobayashi, T., Ode, H., Yoshida, T., Sato, K., Gee, P., Yamamoto, S. P., et al. (2011). Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. J. Virol. 85, 932-945. doi: 10.1128/JVI.01668-10
35. Kueck, T., and Neil, S. J. (2012). A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. PLoS Pathog. 8:e1002609. doi: 10.1371/journal.ppat.1002609
36. Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., and Banting, G. (2003). Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4, 694-709. doi: 10.1034/j.1600-0854.2003.00129.x
37. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Segeral, E., et al. (2011). SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657. doi: 10.1038/nature10117
38. Lau, D., Kwan, W., and Guatelli, J. (2011). Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens. J. Virol. 85, 9834-9846. doi: 10.1128/JVI.02633-10
39. Le Tortorec, A., and Neil, S. J. (2009). Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 83, 11966-11978. doi: 10.1128/JVI.01515-09
40. Magadan, J. G., and Bonifacino, J. S. (2012). Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu. J. Virol. 86, 757-772. doi: 10.1128/JVI.05933-11
41. Magadan, J. G., Perez-Victoria, F. J., Sougrat, R., Ye, Y., Strebel, K., and Bonifacino, J. S. (2010). Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 6:e1000869. doi: 10.1371/journal.ppat.1000869
42. Maldarelli, F., Chen, M. Y., Willey, R. L., and Strebel, K. (1993). Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67, 5056-5061.
43. Malim, M. H., and Bieniasz, P. D. (2012). HIV Restriction factors and mechanisms of evasion. Cold Spring Harb. Perspect. Med. 2:a006940. doi: 10.1101/cshperspect.a006940
44. Malim, M. H., and Emerman, M. (2008). HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3, 388-398. doi: 10.1016/j.chom.2008.04.008
45. Mangeat, B., Gers-Huber, G., Lehmann, M., Zufferey, M., Luban, J., and Piguet, V. (2009). HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 5:e1000574. doi: 10.1371/journal.ppat.1000574
46. Margottin, F., Bour, S. P., Durand, H., Selig, L., Benichou, S., Richard, V., et al. (1998). A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1, 565-574. doi: 10.1016/S1097-2765(00)80056-8
47. Masuyama, N., Kuronita, T., Tanaka, R., Muto, T., Hirota, Y., Takigawa, A., et al. (2009). HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin. J. Biol. Chem. 284, 15927-15941. doi: 10.1074/jbc.M109.005124
48. Matsuda, A., Suzuki, Y., Honda, G., Muramatsu, S., Matsuzaki, O., Nagano, Y., et al. (2003). Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22, 3307-3318. doi: 10.1038/sj.onc.1206406
49. McNatt, M. W., Zang, T., and Bieniasz, P. D. (2013). Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog. 9:e1003299. doi: 10.1371/journal.ppat.1003299
50. Mitchell, R. S., Katsura, C., Skasko, M. A., Fitzpatrick, K., Lau, D., Ruiz, A., et al. (2009). Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5:e1000450. doi: 10.1371/journal.ppat.1000450
51. Miyagi, E., Andrew, A. J., Kao, S., and Strebel, K. (2009). Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U.S.A. 106, 2868-2873. doi: 10.1073/pnas.0813223106
52. Moll, M., Andersson, S. K., Smed-Sorensen, A., and Sandberg, J. K. (2010). Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 116, 1876-1884. doi: 10.1182/blood-2009-09-243667
53. Neil, S. J. (2013). The antiviral activities of tetherin. Curr. Top. Microbiol. Immunol. 371, 67-104. doi: 10.1007/978-3-642-37765-5_3
54. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008). Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430. doi: 10.1038/nature06553
55. Pardieu, C., Vigan, R., Wilson, S. J., Calvi, A., Zang, T., Bieniasz, P., et al. (2010). The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog. 6:e1000843. doi: 10.1371/journal.ppat.1000843
56. Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M. W., Gregory, D. A., Johnson, M. C., et al. (2009). Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139, 499-511. doi: 10.1016/j.cell.2009.08.039
57. Pickering, S., Hue, S., Kim, E. Y., Reddy, S., Wolinsky, S. M., and Neil, S. J. (2014). Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals. PLoS Pathog. 10:e1003895. doi: 10.1371/journal.ppat.1003895
58. Raiborg, C., and Stenmark, H. (2009). The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458, 445-452. doi: 10.1038/nature07961
59. Ray, N., and Doms, R. W. (2006). HIV-1 coreceptors and their inhibitors. Curr. Top. Microbiol. Immunol. 303, 97-120. doi: 10.1007/978-3-540-33397-5_5
60. Rollason, R., Korolchuk, V., Hamilton, C., Schu, P., and Banting, G. (2007). Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J. Cell Sci. 120, 3850-3858. doi: 10.1242/jcs.003343
61. Sauter, D., Schindler, M., Specht, A., Landford, W. N., Munch, J., Kim, K. A., et al. (2009). Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and non-pandemic HIV-1 strains. Cell Host Microbe 6, 409-421. doi: 10.1016/j.chom.2009.10.004
62. Schmidt, S., Fritz, J. V., Bitzegeio, J., Fackler, O. T., and Keppler, O. T. (2011). HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction. MBio 2, e00036-00011. doi: 10.1128/mBio.00036-11
63. Schubert, H. L., Zhai, Q., Sandrin, V., Eckert, D. M., Garcia-Maya, M., Saul, L., et al. (2010). Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations. Proc. Natl. Acad. Sci. U.S.A. 107, 17951-17956. doi: 10.1073/pnas.1008206107
64. Schubert, U., Clouse, K. A., and Strebel, K. (1995). Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69, 7699-7711.
65. Serra-Moreno, R., Jia, B., Breed, M., Alvarez, X., and Evans, D. T. (2011). Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV. Cell Host Microbe 9, 46-57. doi: 10.1016/j.chom.2010.12.005
66. Shah, A. H., Sowrirajan, B., Davis, Z. B., Ward, J. P., Campbell, E. M., Planelles, V., et al. (2010). Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 8, 397-409. doi: 10.1016/j.chom.2010.10.008
67. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650. doi: 10.1038/nature00939
68. Skasko, M., Wang, Y., Tian, Y., Tokarev, A., Munguia, J., Ruiz, A., et al. (2012). HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions. J. Biol. Chem. 287, 58-67. doi: 10.1074/jbc.M111.296772
69. Skaug, B., Jiang, X., and Chen, Z. J. (2009). The role of ubiquitin in NF-kappaB regulatory pathways. Annu. Rev. Biochem. 78, 769-796. doi: 10.1146/annurev.biochem.78.070907.102750
70. Strebel, K., Klimkait, T., and Martin, M. A. (1988). A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241, 1221-1223. doi: 10.1126/science.3261888
71. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., and Sodroski, J. (2004). The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old world monkeys. Nature 427, 848-853. doi: 10.1038/nature02343
72. Tervo, H. M., Homann, S., Ambiel, I., Fritz, J. V., Fackler, O. T., and Keppler, O. T. (2011). Beta-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Retrovirology 8, 9. doi: 10.1186/1742-4690-8-9
73. Tokarev, A., Suarez, M., Kwan, W., Fitzpatrick, K., Singh, R., and Guatelli, J. (2013). Stimulation of NF-kappaB activity by the HIV restriction factor BST2. J. Virol. 87, 2046-2057. doi: 10.1128/JVI.02272-12
74. Tokarev, A. A., Munguia, J., and Guatelli, J. C. (2010). Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu. J. Virol. 85, 51-63. doi: 10.1128/JVI.01795-10
75. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., et al. (2008). The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252. doi: 10.1016/j.chom.2008.03.001
76. Venkatesh, S., and Bieniasz, P. D. (2013). Mechanism of HIV-1 virion entrapment by tetherin. PLoS Pathog. 9:e1003483. doi: 10.1371/journal.ppat.1003483
77. Vigan, R., and Neil, S. J. (2010). Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type-1 (Hiv-1) Vpu protein. J. Virol. 84, 12958-12970. doi: 10.1128/JVI.01699-10
78. Wildum, S., Schindler, M., Munch, J., and Kirchhoff, F. (2006). Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J. Virol. 80, 8047-8059. doi: 10.1128/JVI.00252-06
79. Willey, R. L., Maldarelli, F., Martin, M. A., and Strebel, K. (1992a). Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193-7200.
80. Willey, R. L., Maldarelli, F., Martin, M. A., and Strebel, K. (1992b). Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66, 226-234.
81. Zhang, F., Wilson, S. J., Landford, W. C., Virgen, B., Gregory, D., Johnson, M. C., et al. (2009). Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6, 54-67. doi: 10.1016/j.chom.2009.05.008